Mimedx (MDXG) Cash from Operations (2011 - 2026)
Mimedx recorded quarterly Cash from Operations of 1879000.0 in Q1 2026, down 92.47% quarter-over-quarter from 24956000.0 in Q4 2025, and down 64.54% year-over-year from 5299000.0 in Q1 2025.
Mimedx's Cash from Operations history runs 16 years deep, the most recent figure standing at 1879000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 64.54% year-over-year to 1879000.0; the TTM figure through Mar 2026 stood at 70583000.0 (up 6.22% YoY), while the FY2025 annual figure was 74003000.0, up 10.24% from the prior year.
- Cash from Operations came in at 1879000.0 for Q1 2026 at Mimedx, down from 24956000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 29329000.0 in Q3 2025 to a low of 10223000.0 in Q1 2022.
- A 5-year average of 9518411.76 and a median of 7775000.0 in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations sank 287.93% in 2022 and surged 1233.79% in 2023, its largest moves.
- Mimedx's Cash from Operations stood at 4297000.0 in 2022, then soared by 138.7% to 10257000.0 in 2023, then surged by 92.18% to 19712000.0 in 2024, then rose by 26.6% to 24956000.0 in 2025, then sank by 92.47% to 1879000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 1879000.0, 24956000.0, and 29329000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 1.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.88 Mn |
| Mar 31, 2026 | 1.88 Mn |
| Dec 31, 2025 | 24.96 Mn |
| Dec 31, 2025 | 24.96 Mn |
| Sep 30, 2025 | 29.33 Mn |
| Sep 30, 2025 | 29.33 Mn |
| Jun 30, 2025 | 14.42 Mn |
| Jun 30, 2025 | 14.42 Mn |
| Mar 31, 2025 | 5.30 Mn |
| Mar 31, 2025 | 5.30 Mn |
| Dec 31, 2024 | 19.71 Mn |
| Dec 31, 2024 | 19.71 Mn |
| Sep 30, 2024 | 18.69 Mn |
| Sep 30, 2024 | 18.69 Mn |
| Jun 30, 2024 | 22.74 Mn |
| Jun 30, 2024 | 22.74 Mn |
| Mar 31, 2024 | 5.98 Mn |
| Mar 31, 2024 | 5.98 Mn |
| Dec 31, 2023 | 10.26 Mn |
| Dec 31, 2023 | 10.26 Mn |
| Sep 30, 2023 | 12.79 Mn |
| Sep 30, 2023 | 12.79 Mn |
| Jun 30, 2023 | 7.78 Mn |
| Jun 30, 2023 | 7.78 Mn |
| Mar 31, 2023 | -4.05 Mn |
| Mar 31, 2023 | -4.05 Mn |
| Dec 31, 2022 | 4.30 Mn |
| Dec 31, 2022 | 4.30 Mn |
| Sep 30, 2022 | 959,000.00 |
| Sep 30, 2022 | 959,000.00 |
| Jun 30, 2022 | -3.01 Mn |
| Jun 30, 2022 | -3.01 Mn |
| Mar 31, 2022 | -10.22 Mn |
| Mar 31, 2022 | -10.22 Mn |
| Dec 31, 2021 | -11.12 Mn |
| Dec 31, 2021 | -11.12 Mn |
| Sep 30, 2021 | 6.33 Mn |
| Sep 30, 2021 | 6.33 Mn |
| Jun 30, 2021 | 1.60 Mn |
| Jun 30, 2021 | 1.60 Mn |
| Mar 31, 2021 | -6.68 Mn |
| Mar 31, 2021 | -6.68 Mn |
| Dec 31, 2020 | -10.27 Mn |
| Dec 31, 2020 | -10.27 Mn |
| Sep 30, 2020 | -4.62 Mn |
| Sep 30, 2020 | -4.62 Mn |
| Jun 30, 2020 | -3.10 Mn |
| Jun 30, 2020 | -3.10 Mn |
| Mar 31, 2020 | -12.28 Mn |
| Mar 31, 2020 | -12.28 Mn |
| Dec 31, 2019 | -23.12 Mn |
| Dec 31, 2019 | -23.12 Mn |
| Sep 30, 2019 | -3.16 Mn |
| Sep 30, 2019 | -3.16 Mn |
| Jun 30, 2019 | 2.13 Mn |
| Jun 30, 2019 | 2.13 Mn |
| Mar 31, 2019 | -15.26 Mn |
| Mar 31, 2019 | -15.26 Mn |
| Dec 31, 2018 | 1.53 Mn |
| Dec 31, 2018 | 1.53 Mn |
| Sep 30, 2018 | 3.40 Mn |
| Sep 30, 2018 | 3.40 Mn |
| Jun 30, 2018 | 20.69 Mn |
| Jun 30, 2018 | 20.69 Mn |
| Mar 31, 2018 | 10.18 Mn |
| Mar 31, 2018 | 10.18 Mn |
| Dec 31, 2017 | 20.87 Mn |
| Dec 31, 2017 | 20.87 Mn |
| Sep 30, 2017 | 17.95 Mn |
| Sep 30, 2017 | 17.95 Mn |
| Jun 30, 2017 | 13.48 Mn |
| Jun 30, 2017 | 13.48 Mn |
| Mar 31, 2017 | 10.64 Mn |
| Mar 31, 2017 | 10.64 Mn |
| Dec 31, 2016 | 14.70 Mn |
| Dec 31, 2016 | 14.70 Mn |
| Sep 30, 2016 | 2.85 Mn |
| Sep 30, 2016 | 2.85 Mn |
| Jun 30, 2016 | 7.28 Mn |
| Jun 30, 2016 | 7.28 Mn |
| Mar 31, 2016 | -977,000.00 |
| Mar 31, 2016 | -977,000.00 |
| Dec 31, 2015 | 4.36 Mn |
| Dec 31, 2015 | 4.36 Mn |
| Sep 30, 2015 | 7.31 Mn |
| Sep 30, 2015 | 7.31 Mn |
| Jun 30, 2015 | 2.93 Mn |
| Jun 30, 2015 | 2.93 Mn |
| Mar 31, 2015 | 4.21 Mn |
| Mar 31, 2015 | 4.21 Mn |
| Dec 31, 2014 | 8.29 Mn |
| Dec 31, 2014 | 8.29 Mn |
| Sep 30, 2014 | 8.95 Mn |
| Sep 30, 2014 | 8.95 Mn |
| Jun 30, 2014 | 1.18 Mn |
| Jun 30, 2014 | 1.18 Mn |
| Mar 31, 2014 | -1.61 Mn |
| Mar 31, 2014 | -1.61 Mn |
| Dec 31, 2013 | 840,663.00 |
| Dec 31, 2013 | 840,663.00 |
| Sep 30, 2013 | 1.73 Mn |
| Sep 30, 2013 | 1.73 Mn |
| Jun 30, 2013 | -755,362.00 |
| Jun 30, 2013 | -755,362.00 |
| Mar 31, 2013 | -2.10 Mn |
| Mar 31, 2013 | -2.10 Mn |
| Dec 31, 2012 | -870,887.00 |
| Dec 31, 2012 | -870,887.00 |
| Sep 30, 2012 | -862,302.00 |
| Sep 30, 2012 | -862,302.00 |
| Jun 30, 2012 | -310,872.00 |
| Jun 30, 2012 | -310,872.00 |
| Mar 31, 2012 | -1.29 Mn |
| Mar 31, 2012 | -1.29 Mn |
| Dec 31, 2011 | -1.66 Mn |
| Dec 31, 2011 | -1.66 Mn |
| Sep 30, 2011 | -1.09 Mn |
| Sep 30, 2011 | -1.09 Mn |
| Jun 30, 2011 | -2.13 Mn |
| Jun 30, 2011 | -2.13 Mn |
| Mar 31, 2011 | -1.79 Mn |
| Mar 31, 2011 | -1.79 Mn |